ESR1 and breast cancer: The clinical importance of histone isoforms is highlighted by recent reports that identified alterations in specific histone H2A isoforms in B cells isolated from patients with chronic lymphocytic leukemia (CLL) and in estrogen receptor positive breast cancer tissues [15–17].